Acute myeloid leukemia (AML) remains harder to treat therapeutically due to the high existing genetic heterogeneity not only between patients but also between the population of subclones of cancer cells within the same person. ...
Mar 30, 2022
0
48
The molecular processes caused by a TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) gene mutation in the brain's microglia immune cells can increase the risk of Alzheimer's disease, according to a recent study led ...
Mar 23, 2022
0
8
It's a diagnosis you never want to hear: acute myeloid leukemia (AML). These three words represent a devastating diagnosis of childhood cancer with dire consequences for many families.
Mar 21, 2022
0
29
An international team of researchers has developed a way to replace almost all of the microglia cells in a mouse brain using circulation-derived myeloid cells as a way to treat neurodegenerative disease using a technique ...
More effective therapies are needed for acute leukemia, particularly for people over 50 years of age at diagnosis, according to research published today by the Medical Journal of Australia.
Mar 14, 2022
0
2
In order to better treat patients diagnosed with acute myeloid leukemia (AML), the pathological processes and also existing subtypes of the disease must be better understood. With the help of proteome and genome analysis, ...
Mar 4, 2022
0
27
New research from the University of East Anglia (UEA) and Quadram Institute reveals how our immune system can be triggered to attack cancer cells.
Mar 1, 2022
0
80
Optical genome mapping involves the extraction of very long DNA molecules, for example routinely collected blood samples or bone marrow material from patients. These long DNA molecules are labeled with dye molecules at more ...
Feb 17, 2022
0
19
Acute myeloid leukemia, which affects blood and bone marrow cells, is a particularly dangerous form of cancer. More than half of patients under the age of 60 die. This proportion rises to 85% for patients over 60. A team ...
Feb 17, 2022
0
55
A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation ...
Feb 15, 2022
0
5
